EVER Valinject is a division of EVER Pharma focused on the development, production and commercialization of complex and value-added injectable formulations that support compliance, convenience and safety for the patients and healthcare professionals. Our R&D team is extensively engaged in the development of a broad portfolio of products in the therapeutic areas of critical care, anesthesia and oncology for global markets.

In addition to our internal development pipeline, we are also interested in broadening our injectable portfolio through in-licensing, acquisition and partnerships.

Visit our website: www.evervalinject.com